Intralesional PV‐10 for the treatment of in‐transit melanoma metastases—Results of a prospective, non‐randomized, single center study

BACKGROUND: Patients with in‐transit melanoma metastases frequently experience high rates of recurrence, limited overall survival and reduced quality of life. After promising results within a Phase II, multi‐center study, PV‐10 treatment was continued at our institution for patients with in‐transit...

Descripción completa

Detalles Bibliográficos
Autores principales: Read, Tavis A., Smith, Aaron, Thomas, Janine, David, Michael, Foote, Matthew, Wagels, Michael, Barbour, Andrew, Smithers, B. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668008/
https://www.ncbi.nlm.nih.gov/pubmed/29529343
http://dx.doi.org/10.1002/jso.24921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668008/
https://www.ncbi.nlm.nih.gov/pubmed/29529343
http://dx.doi.org/10.1002/jso.24921

Ejemplares similares